Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 10:19 am Sale |
2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 0 0.000% |
-3,710,412 (Position Closed) |
Filing History |
| 2024-02-14 8:26 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Venrock Healthcare Capital Partners III L.P. | 2,070,000 3.300% |
2,070,000 (New Position) |
Filing History |
| 2024-02-14 5:08 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
SHAW D E & CO L P | 4,240,486 6.700% |
4,240,486 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Paradigm BioCapital Advisors LP | 4,502,689 7.100% |
4,502,689 (New Position) |
Filing History |
| 2024-02-14 4:05 pm Unchanged |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Commodore Capital LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:03 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Cormorant Asset Management LP | 11,231,000 17.780% |
11,231,000 (New Position) |
Filing History |
| 2024-02-14 11:31 am Unchanged |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.880% |
0 (Unchanged) |
Filing History |
| 2024-02-12 4:15 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
HOPU Reunion Co Ltd | 1,060,000 1.700% |
1,060,000 (New Position) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | Ambrx Biopharma Inc. AMAM |
FMR CORP | 1,474,258 2.334% |
1,474,258 (New Position) |
Filing History |
| 2024-02-05 4:15 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
WuXi PharmaTech Healthcare Fund I L.P. | 1,000,000 1.600% |
1,000,000 (New Position) |
Filing History |
| 2023-11-02 4:15 pm Purchase |
2023-11-01 | 13G | Ambrx Biopharma Inc. AMAM |
Nextech Crossover I GP S.a r.l. | 3,129,300 5.000% |
3,129,300 (New Position) |
Filing History |
| 2023-11-02 4:09 pm Purchase |
2023-10-23 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.650% |
3,710,412 (New Position) |
Filing History |